Wall Street Experts
ver. ZuMIgo(08/25)
Pure Biologics Spólka Akcyjna
Rachunek Zysków i Strat
Przychody TTM (mln): 0
EBIT TTM (mln): -15
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
Rok finansowy |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
Przychód (mln) |
1 |
1 |
10 |
17 |
1 |
0 |
1 |
0 |
Przychód Δ r/r |
0.0% |
-23.8% |
870.8% |
75.8% |
-96.6% |
-55.6% |
160.6% |
-85.6% |
Marża brutto |
86.1% |
89.5% |
70.2% |
76.4% |
52.3% |
-1585.4% |
-816.8% |
-2709.5% |
EBIT (mln) |
-0 |
-0 |
-1 |
-4 |
-12 |
-10 |
-25 |
-32 |
EBIT Δ r/r |
0.0% |
-7.9% |
63.4% |
592.1% |
164.6% |
-9.3% |
135.0% |
28.8% |
EBIT (%) |
-32.5% |
-39.3% |
-6.6% |
-26.1% |
-2020.3% |
-4126.8% |
-3720.4% |
-33387.4% |
Koszty finansowe (mln) |
-0 |
0 |
0 |
0 |
0 |
0 |
0 |
4 |
EBITDA (mln) |
-0 |
-0 |
-0 |
-4 |
-8 |
-8 |
-22 |
-24 |
EBITDA(%) |
-29.8% |
-25.2% |
-4.9% |
-21.8% |
-1450.5% |
-2968.1% |
-3324.5% |
-25423.2% |
Podatek (mln) |
-0 |
-0 |
-0 |
0 |
0 |
1 |
1 |
2 |
Zysk Netto (mln) |
-0 |
-0 |
-1 |
-5 |
-12 |
-13 |
-26 |
-36 |
Zysk netto Δ r/r |
0.0% |
-4.7% |
67.0% |
582.5% |
157.3% |
8.0% |
101.8% |
35.3% |
Zysk netto (%) |
-33.6% |
-42.0% |
-7.2% |
-28.1% |
-2116.3% |
-5146.1% |
-3983.7% |
-37572.6% |
EPS |
-0.81 |
-0.77 |
-0.59 |
-3.09 |
-7.32 |
-5.88 |
-11.87 |
-11.19 |
EPS (rozwodnione) |
-0.37 |
-0.35 |
-0.59 |
-3.09 |
-7.32 |
-5.88 |
-11.87 |
-10.85 |
Ilośc akcji (mln) |
1 |
1 |
1 |
2 |
2 |
2 |
2 |
3 |
Ważona ilośc akcji (mln) |
1 |
1 |
1 |
2 |
2 |
2 |
2 |
3 |
Waluta |
PLN |
PLN |
PLN |
PLN |
PLN |
PLN |
PLN |
PLN |